Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 206
Selected: 0
NCT IDTitle
NCT04762407A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903
NCT05711381Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function
NCT05598151Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
NCT02026817Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg
NCT03744182A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
NCT03372850Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations
NCT05024721Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
NCT07784296Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension
NCT02390882A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH
NCT05555238An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
NCT01764087A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors
NCT01830517Diurnal Variation in Hypertensive Stroke Patients
NCT05656092A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
NCT07205900Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
NCT05481307A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203
NCT01913847Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
NCT04325620Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease
NCT04032782A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects
NCT07379333A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
NCT04324918Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis
NCT05407220A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.
NCT01509196A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet
NCT04505436Efocipegtrutide (HM15211) in Adults With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)
NCT04080726Efficacy and Safety of HIP1601 Capsule
NCT01491204Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer
NCT01037543Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects
NCT04820907Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
NCT03332849Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus
NCT05845489Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
NCT02418689Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
NCT02057887Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)
NCT05191563A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.
NCT01548157Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule
NCT07359105Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
NCT01555398Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule
NCT02554136Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816
NCT06346184A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers
NCT04830449Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
NCT01718847NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors
NCT02444819Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy
NCT03666351Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
NCT05487560An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding
NCT01901757Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers
NCT02545829Evaluating the Bioequivalence of HIP1302, HGP1406
NCT04768686FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
NCT07527650Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
NCT04084197A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects.
NCT04084184A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects
NCT02941796Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers
NCT06234397Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors